HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamamoto, F. Articles by Hearse, D. J. Search for Related Content PubMed PubMed Citation Articles by Yamamoto, F. Articles by Hearse, D. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 86, 252-261, Copyright © 1983 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Cardioplegia and slow calcium-channel blockers. Studies with verapamil

F Yamamoto, AS Manning, MV Braimbridge and DJ Hearse

The ability of dl-verapamil to enhance myocardial protection when given before, during, or after myocardial ischemia was assessed with the use of an isolated working rat heart model of cardiopulmonary bypass and ischemic cardiac arrest. Under conditions of normothermic ischemic arrest (30 minutes at 37 degrees C), the addition of verapamil enhanced the protective properties of the St. Thomas' Hospital cardioplegic solution. Optimal protection was observed with verapamil concentrations of 0.5 mg/L (1.09 mumol/L) of cardioplegic solution. Under these conditions, postischemic enzyme leakage was reduced by 32.2% and the postischemic recovery of aortic flow was improved by 18.7%. Despite the additional protection at normothermia, the drug at several concentrations appeared unable to improve functional recovery after an extended period of hypothermic arrest (150 minutes at 20 degrees C), although under these conditions its inclusion in the cardioplegic solution could substantially reduce enzyme leakage. In other studies, the ability of various doses of verapamil alone as a substitute for the cardioplegic solution was examined. At the optimal dose (again 0.5 mg/L), and under normothermic conditions, verapamil alone was a good protection against ischemic injury, although this protection did not match that afforded by the St. Thomas' Hospital cardioplegic solution. In similar studies under hypothermic conditions, the drug failed to afford tissue protection, perhaps indicating some common modality between hypothermia and verapamil-induced protection. Pretreatment with verapamil (0.1 mg/L) prior to ischemia offered moderate additional protection, but its use during reperfusion failed to enhance overall recovery.

This article has been cited by other articles:

				U. Acikel, E. Hazan, N. Sariosmanoglu, H. Catalyurek, E. Silistreli, G. Guner, N. Saydam, Y. Tuncok, H. Guven, O. Karabay, et al. Nisoldipine Cardioplegia in the Isolated Rabbit Heart Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 285 - 290. [Abstract] [PDF]

				N. Takemoto, H. Kuroda, T. Hamasaki, Y. Hara, S. Ishiguro, and T. Mori Effect of magnesium and calcium on myocafdial protection by cardioplegic solutions Ann. Thorac. Surg., January 1, 1994; 57(1): 177 - 182. [Abstract] [PDF]

				M. E. Mitchell, D. A. DeBoer, M. D. Crittenden, and R. E. Clark Nicardipine: Myocardial protection in isolated working hearts Ann. Thorac. Surg., October 1, 1992; 54(4): 712 - 716. [Abstract] [PDF]

				M. V. Braimbridge Research and the practicing surgeon Ann. Thorac. Surg., May 1, 1990; 49(5): 694 - 700. [PDF]

				G. S. Weinstein, P. S. Rao, and D. H. Tyras Reduction of myocardial injury with verapamil before aortic cross-clamping Ann. Thorac. Surg., March 1, 1990; 49(3): 419 - 423. [Abstract] [PDF]

				E. Hochhauser, Y. Barak, S. Einav, S. Cohen, and B. Vidne Effect of Experimental Cardioplegia Methods on Normal and Hypertrophied Rat Hearts Ann. Thorac. Surg., August 1, 1988; 46(2): 208 - 213. [Abstract] [PDF]

				R. E. Clark Verapamil, Cardioplegia, and Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 1986; 41(6): 585 - 586. [PDF]

				A. V. Guffin, R. A. Kates, G. W. Holbrook, E. L. Jones, and J. A. Kaplan Verapamil and Myocardial Preservation in Patients Undergoing Coronary Artery Bypass Surgery Ann. Thorac. Surg., June 1, 1986; 41(6): 587 - 591. [Abstract] [PDF]

				M. Chiavarelli, R. Chiavarelli, A. Macchiarelli, A. Carpi, and B. Marino Calcium Entry Blockers and Cardioplegia: Interaction Between Nifedipine, Potassium, and Hypothermia Ann. Thorac. Surg., May 1, 1986; 41(5): 535 - 541. [Abstract] [PDF]

				G. L. Hicks Jr. and J. A. DeWeese Verapamil Potassium Cardioplegia and Cardiac Conduction Ann. Thorac. Surg., April 1, 1985; 39(4): 324 - 328. [Abstract] [PDF]

				G. L. Hicks Jr., R. K. Salley, and J. A. DeWeese Calcium Channel Blockers: An Intraoperative and Postoperative Trial in Women Ann. Thorac. Surg., April 1, 1984; 37(4): 319 - 323. [Abstract] [PDF]